Phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer

被引：1
|
作者：
Dawson, L. [1 ]
Hawkins, M. [1 ]
Eccles, C. [1 ]
Craig, T. [1 ]
Bissonnette, J-P. [1 ]
Lockwood, G. [1 ]
Zhang, J. [1 ]
Kim, J. [1 ]
Cummings, B. [1 ]
Sherman, M. [1 ]
Knox, J. [1 ]
Gallinger, S. [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80805-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
64
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [21] Stereotactic body radiotherapy (SBRT) in combination with surgery for primary and metastatic liver tumors
    Lappinen, Erik
    Thai, Ngoc
    Tom, Kusum
    Khan, Akhtar
    Day, Ellen
    Green, William Ross
    Christensen, James
    Kirichenko, Alexander V.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [22] Stereotactic radiotherapy (SRT) for primary and metastatic liver tumors with functional treatment planning
    Kirichenko, Alexander V.
    Ngoc Thai
    Lappinen, Erik
    Gayou, Olivier
    Day, Ellen
    Kotinsley, Katherine
    Gott, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [23] A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
    Iwashita, Y
    Tahara, K
    Goto, S
    Sasaki, A
    Kai, S
    Seike, M
    Chen, CL
    Kawano, K
    Kitano, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (03) : 155 - 161
  • [24] A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
    Yukio Iwashita
    Kouichirou Tahara
    Shigeru Goto
    Atsushi Sasaki
    Seiichiro Kai
    Masataka Seike
    Chao-Long Chen
    Katsunori Kawano
    Seigo Kitano
    Cancer Immunology, Immunotherapy, 2003, 52 : 155 - 161
  • [25] Stereotactic body radiotherapy using Cyber Knife for locally advanced unresectable and metastatic pancreatic cancer
    Ting-Shi Su
    Ping Liang
    Huan-Zhen Lu
    Jian-Ning Liang
    Jian-Min Liu
    Ying Zhou
    Ying-Chuan Gao
    Min-Yang Tang
    World Journal of Gastroenterology, 2015, (26) : 8156 - 8162
  • [26] Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study
    James, RD
    Botwood, N
    Vernon, CC
    Price, P
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 570 - 573
  • [27] Stereotactic radiotherapy in metastatic breast cancer
    Possanzini, Marco
    Greco, Carlo
    BREAST, 2018, 41 : 57 - 66
  • [28] A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic colorectal cancer (CRC).
    Turk, Anita Ahmed
    Lubner, Sam Joseph
    Uboha, Nataliya Volodymyrivna
    LoConte, Noelle K.
    Mulkerin, Daniel
    Kim, David H.
    Matkowskyj, Kristina
    Weber, Sharon M.
    Abbott, Daniel
    Eickhoff, Jens C.
    Bassetti, Michael F.
    Deming, Dustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [29] Phase I study of a chloroquine–gemcitabine combination in patients with metastatic or unresectable pancreatic cancer
    Panagiotis Samaras
    Marina Tusup
    Thi Dan Linh Nguyen-Kim
    Burkhardt Seifert
    Helga Bachmann
    Roger von Moos
    Alexander Knuth
    Steve Pascolo
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 1005 - 1012
  • [30] Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
    Jung, Da Hoon
    Kim, Mi-Sook
    Cho, Chul Koo
    Yoo, Hyung Jun
    Il Jang, Won
    Seo, Young Seok
    Paik, Eun Kyung
    Kim, Kum Bae
    Han, Chul Ju
    Kim, Sang Bum
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (03): : 163 - 169
12345